NCT02125019View on ClinicalTrials.gov

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

December 4, 2013

Primary Completion Date

May 14, 2018

Study Completion Date

May 14, 2018

Conditions
Breast Cancer
Trial Locations (1)

43210

Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT02125019 - Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter